The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Schizophrenia: A neural diathesis-stress model.
Walker, E. F., & Diforio, D. (1997) · Psychological Review · doi:10.1037//0033-295x.104.4.667 · Cited by 930
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784 · cited 1×
“Growing evidence suggests that, in addition to providing communication between immune cells, specific cytokines play a role in signaling the brain to produce neurochemical, neuroendocrine, neuroimmune, and behavioral changes (Muller and Ackenheil, 1998; Kronfol and Remick, 2000).”
BackgroundBethin, K. E., Vogt, S. K., & Muglia, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9317 · Cited by 381 · cited 3×
“Communication between these systems plays an essential role in modulating the adequate response of the hypothalamic–pituitary–adrenal (HPA) axis to the stimulatory influence of cytokines and stress-related mediators (”
BackgroundTandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90353-n · Cited by 168
Maes, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00062-0 · Cited by 156
Increased prevalence of antibrain antibodies in the sera from schizophrenic patients
Henneberg, A. E., Horter, S., & Ruffert, S. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90004-3 · Cited by 87 · cited 2×
“Muller et al , 1993 ), the presence of antibrain antibodies in serum (”
BackgroundKaneko, M., Yokoyama, F., Hoshino, Y., Takahagi, K., Murata, S., Watanabe, M., & Kumashiro, H. (2008) · Neuropsychobiology · doi:10.1159/000118800 · Cited by 70 · cited 3×
“…suggest a relationship between HPA activity and symptomatology in SCH. Cortisol secretion has been associated with more severe positive symptoms (Kaneko et al, 1992; Walder et al, 2000), whereas in others it was associated with higher ratings of negative symptoms (Newcomer et al, 1991; Tandon…”
Background
Cited by
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615
The dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
Pruessner, M., Cullen, A. E., Aas, M., & Walker, E. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.013 · Cited by 315
“The most common effect is a dampening of HPA activity documented with atypical antipsychotics (Zhang et al., 2005, Cohrs et al., 2006, Venkatasubramanian et al., 2010) and some antidepressants (Manthey et al., 2011).”
BackgroundCortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv028 · Cited by 286
Mondelli, V., Dazzan, P., Hepgul, N., Di Forti, M., Aas, M., D'Albenzio, A., Di Nicola, M., Fisher, H., Handley, R., Marques, T. R., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.08.013 · Cited by 278
Juster, R.-P., Bizik, G., Picard, M., Arsenault-Lapierre, G., Sindi, S., Trepanier, L., Marin, M.-F., Wan, N., Sekerovic, Z., Lord, C., et al. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000289 · Cited by 268
Drexhage, R. C., Knijff, E. M., Padmos, R. C., Heul-Nieuwenhuijzen, L. V. D., Beumer, W., Versnel, M. A., & Drexhage, H. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.144 · Cited by 263
Meyer, U., Schwarz, M. J., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 258
Bradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Tourjman, V., Kouassi, É., Koué, M.-È., Rocchetti, M., Fortin-Fournier, S., Fusar-Poli, P., & Potvin, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.011 · Cited by 224
Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis
Girshkin, L., Matheson, S. L., Shepherd, A. M., & Green, M. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.013 · Cited by 215
Borges, S., Gayer-Anderson, C., & Mondelli, V. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.025 · Cited by 153
“Indeed, previous studies in patients with chronic schizophrenia have shown that both first and second generation antipsychotics affect cortisol levels, and increasing evidence suggests that second generation antipsychotics reduce cortisol to a greater extent than first generation ones (Zhang et al., 2005; Popovic et a…”
Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis
Belvederi Murri, M., Pariante, C. M., Dazzan, P., Hepgul, N., Papadopoulos, A. S., Zunszain, P., Di Forti, M., Murray, R. M., & Mondelli, V. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.013 · Cited by 93
“Most studies looking at the association between HPA axis activity and clinical symptoms in psychosis have focussed on patients with chronic schizophrenia (Franzen, 1971; Munro et al., 1984; Altamura et al., 1989; Kaneko et al., 1992; Shirayama et al., 2002; Halari et al., 2004; Zhang et al., 2005; Ritsner et al., 2007…”
BackgroundResultInfluentialImmune and Neuroimmune Alterations in Mood Disorders and Schizophrenia
Drexhage, R. C., Weigelt, K., van Beveren, N., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2011) · International Review of Neurobiology · doi:10.1016/b978-0-12-387718-5.00007-9 · Cited by 71
Pituitary volume in neuroleptic-naïve schizophrenia: A structural MRI study
UPADHYAYA, A., ELSHEIKH, R., MACMASTER, F., DIWADKAR, V, & KESHAVAN, M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.09.033 · Cited by 51
Enlarged hypothalamic volumes in schizophrenia
Tognin, S., Rambaldelli, G., Perlini, C., Bellani, M., Marinelli, V., Zoccatelli, G., Alessandrini, F., Pizzini, F. B., Beltramello, A., Terlevic, R., et al. (2012) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2012.10.006 · Cited by 47
Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers
Handley, R., Mondelli, V., Zelaya, F., Marques, T., Taylor, H., Reinders, A. A. T. S., Chaddock, C., McQueen, G., Hubbard, K., Papadopoulos, A., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.039 · Cited by 42
“Understanding the differential effects of FGAs and SGAs will help clarify whether the level of antagonism at D2, or other neurotransmitter receptors, such as the serotonin, are important in regulating cortisol and IL-6 levels, and whether these biomarkers mediate the drug-induced changes evident in hippocampal rCBF.”
BackgroundInfluentialSun, H.-Q., Li, S.-X., Chen, F.-B., Zhang, Y., Li, P., Jin, M., Sun, Y., Wang, F., Mi, W.-F., Shi, L., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.013 · Cited by 42
Abnormal stress responsiveness and suicidal behavior: a risk phenotype
Steinberg, L. J., & Mann, J. J. (2020) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100011 · Cited by 29
Modulation of HPA axis response to social stress in schizophrenia by childhood trauma
Lange, C., Huber, C. G., Fröhlich, D., Borgwardt, S., Lang, U. E., & Walter, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.03.027 · Cited by 27
Ho, R. T. H., Fong, T. C. T., Wan, A. H. Y., Au-Yeung, F. S. W., Chen, E. Y. H., & Spiegel, D. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.014 · Cited by 19
Metadata
- Authors
- Zhang, X. Y., Zhou, D. F., Cao, L. Y., Wu, G. Y., & Shen, Y. C.
- Venue
- Neuropsychopharmacology
- Published
- 2005-05-11
- Volume
- 30
- Issue
- 8
- Pages
- 1532-1538
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2050463389
- Cited by
- 209
- References
- 8
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.